MONOTHERAPY, ADULT AND CHILD OVER 12 YEARS, INITIALLY 25 MG DAILY FOR 14 DAYS, INCREASED TO 50 MG DAILY FOR FURTHER 14 DAYS, THEN INCREASED BY MAX. 50 - 100 MG DAILY EVERY 7 - 14 DAYS; USUAL MAINTENANCE 100 - 200 MG DAILY IN 1 - 2 DIVIDED DOSES (UP TO 500 MG DAILY HAS BEEN REQUIRED)
IN PATIENTS TAKING ENZYME INDUCING AEDS WITH/WITHOUT OTHER AEDS (EXCEPT VALPROATE): INITIAL DOSE IS 50 MG DAILY FOR 2 WEEKS, FOLLOWED BY 100 MG/DAY GIVEN IN TWO DIVIDED DOSES FOR TWO WEEKS. THEREAFTER THE DOSE SHOULD BE INCREASED BY A MAXIMUM OF 100 MG EVERY 1-2 WEEKS UNTIL THE OPTIMAL RESPONSE IS OBTAINED. THE USUAL MAINTENANCE DOSE IS 200-400 MG DAILY IN TWO DIVIDED DOSES.
IN PATIENT WITH SODIUM VALPROATE WITH/WITHOUT ANY OTHER ANTI-EPILEPTIC DRUG (AED): THE INITIAL DOSE IS 25 MG EVERY ALTERNATE DAY FOR 2 WEEKS. THEREAFTER, THE DOSES SHOULD BE INCREASED BY A MAXIMUM OF 25-50 MG EVERY 1-2 WEEKS UNTIL OPTIMAL RESPONSE IS ACHIEVED. THE USUAL MAINTENANCE DOSE IS 100-200 MG DAILY IN ONE OR TWO DIVIDED DOSES.
ADJUNCTIVE THERAPY WITH OXCARBAZEPINE, INITIALLY 25 MG DAILY FOR 14 DAYS, INCREASED TO 50 MG DAILY FOR FURTHER 14 DAYS, THEN INCREASED BY MAX. 50 - 100 MG DAILY EVERY 7 - 14 DAYS; USUAL MAINTENANCE 100 - 200 MG DAILY IN 1 - 2 DIVIDED DOSES; CHILD 2 - 12 YEARS INITIALLY 300 MICROGRAMS/KG DAILY IN 1 - 2 DIVIDED DOSES FOR 14 DAYS THEN 600 MICROGRAMS/KG DAILY IN 1 - 2 DIVIDED DOSES FOR FURTHER 14 DAYS, THEREAFTER INCREASED BY MAX. 600 MICROGRAMS/KG DAILY EVERY 7 - 14 DAYS; USUAL MAINTENANCE 1 - 10 MG/KG DAILY IN 1 - 2 DIVIDED DOSES; MAX. 200 MG DAILY